Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword
Heart failure (HF) is a rapidly growing pandemic while medical treatment options remain limited. Omecamtiv mecarbil (OM) is a novel HF drug that directly targets the myosin heads of the cardiac muscle. This study used living myocardial slices (LMS) from patients with HF to evaluate the direct biomec...
Shranjeno v:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2023-09-01
|
| Serija: | Journal of Molecular and Cellular Cardiology Plus |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S2772976123000107 |
| Oznake: |
Brez oznak, prvi označite!
|